Endovascular treatment of carotid-cavernous fistulas in a medium-sized Scandinavian neurovascular center.

IF 0.9 Q4 OPHTHALMOLOGY

Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery Pub Date : 2025-01-20 DOI:10.1080/01676830.2024.2448802

Svein Harald Mørkve, Gaute Kjellevold Wathle, Nicola Logallo

{"title":"Endovascular treatment of carotid-cavernous fistulas in a medium-sized Scandinavian neurovascular center.","authors":"Svein Harald Mørkve, Gaute Kjellevold Wathle, Nicola Logallo","doi":"10.1080/01676830.2024.2448802","DOIUrl":null,"url":null,"abstract":"Purpose: Carotid-cavernous fistulas (CCFs) are treated almost exclusively by endovascular techniques, but the frequency of treatments is limited in smaller centers. We analyzed all CCFs treated in our hospital to determine if high-quality treatment of CCFs can be provided in a medium-volume neurovascular center.Methods: Retrospective quality-control cohort study.Results: From 2005 to 2021, 28 CCF-treatments were performed in our hospital, all endovascular. Fourteen were direct and fourteen were indirect CCFs. All direct CCFs were treated using transarterial coil embolization, and in seven of these the ICA was preserved. All indirect CCFs were treated using transvenous coil embolization. Complete cure was achieved after one procedure in 24 (85.7%) patients, and in all patients (100%) after retreatments. All CCF-patients experienced significant improvement of symptoms after treatment and 79.2% were asymptomatic after 6-12 months. Two patients with direct CCFs were blind on their ipsilateral eye before treatment and remained so after treatment. Three patients had reduced vision or visual field defects ipsilateral to their indirect CCFs that normalized after treatment. One patient suffered a minor asymptomatic thromboembolic event during the treatment (3.6%), otherwise there were no complications to treatments.Conclusions: High-quality treatment of CCFs can be provided in a medium-volume neurovascular center.","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"1-8"},"PeriodicalIF":0.9000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/01676830.2024.2448802","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Carotid-cavernous fistulas (CCFs) are treated almost exclusively by endovascular techniques, but the frequency of treatments is limited in smaller centers. We analyzed all CCFs treated in our hospital to determine if high-quality treatment of CCFs can be provided in a medium-volume neurovascular center.

Methods: Retrospective quality-control cohort study.

Results: From 2005 to 2021, 28 CCF-treatments were performed in our hospital, all endovascular. Fourteen were direct and fourteen were indirect CCFs. All direct CCFs were treated using transarterial coil embolization, and in seven of these the ICA was preserved. All indirect CCFs were treated using transvenous coil embolization. Complete cure was achieved after one procedure in 24 (85.7%) patients, and in all patients (100%) after retreatments. All CCF-patients experienced significant improvement of symptoms after treatment and 79.2% were asymptomatic after 6-12 months. Two patients with direct CCFs were blind on their ipsilateral eye before treatment and remained so after treatment. Three patients had reduced vision or visual field defects ipsilateral to their indirect CCFs that normalized after treatment. One patient suffered a minor asymptomatic thromboembolic event during the treatment (3.6%), otherwise there were no complications to treatments.

Conclusions: High-quality treatment of CCFs can be provided in a medium-volume neurovascular center.

查看原文本刊更多论文

斯堪的纳维亚中型神经血管中心颈动脉-海绵状瘘管的血管内治疗。

目的：颈动脉海绵状瘘管（CCFs）的治疗几乎完全通过血管内技术，但治疗频率在较小的中心是有限的。我们分析了在我院治疗的所有CCFs，以确定是否可以在中等容量的神经血管中心提供高质量的CCFs治疗。方法：回顾性质量控制队列研究。结果：2005年至2021年，我院共行ccf治疗28例，均为血管内治疗。14例为直接CCFs， 14例为间接CCFs。所有直接CCFs均采用经动脉线圈栓塞治疗，其中7例ICA得以保留。所有间接CCFs均采用经静脉线圈栓塞治疗。24例（85.7%）患者在一次手术后完全治愈，所有患者（100%）在再次治疗后完全治愈。所有ccf患者在治疗后症状均有显著改善，79.2%的患者在6-12个月后无症状。2例直接CCFs患者治疗前同侧眼失明，治疗后仍失明。3例患者的视力下降或视野缺损与间接CCFs同侧，治疗后恢复正常。1例患者在治疗期间出现轻微的无症状血栓栓塞事件（3.6%），其他治疗无并发症。结论：在中等容量的神经血管中心可以提供高质量的CCFs治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery OPHTHALMOLOGY-

CiteScore

2.40

自引率

9.10%

发文量

136

期刊介绍： Orbit is the international medium covering developments and results from the variety of medical disciplines that overlap and converge in the field of orbital disorders: ophthalmology, otolaryngology, reconstructive and maxillofacial surgery, medicine and endocrinology, radiology, radiotherapy and oncology, neurology, neuroophthalmology and neurosurgery, pathology and immunology, haematology.